Please use this identifier to cite or link to this item:http://hdl.handle.net/20.500.12105/9005
Title
Influenza vaccine effectiveness in Spain 2013/14: subtype-specific early estimates using the cycEVA study
Author(s)
Jimenez-Jorge, Silvia ISCIII | Pozo Sanchez, Francisco ISCIII | Mateo-Ontañon, Salvador de ISCIII | Delgado-Sanz, Concepcion ISCIII | Casas Flecha, Inmaculada ISCIII | Garcia-Cenoz, Manuel ISCIII | Castilla, Jesus ISCIII | Sancho, R | Etxebarriarteun-Aranzabal, L | Quinones, C | Martinez, E | Vega, T | Garcia, A | Gimenez, J | Vanrell, J M | Castrillejo, D | Larrauri, Amparo ISCIII
Date issued
2014-03-06
Citation
Euro Surveill. 2014 Mar 6;19(9). pii: 20727.
Language
Inglés
Abstract
Adjusted early estimates of the 2013/14 influenza vaccine effectiveness (VE) in Spain for all age groups was 35% (95% CI: -9 to 62), 33% (95% CI: -33 to 67) and 28% (95% CI: -33 to 61) against any influenza virus type, A(H1N1)pdm09 and A(H3N2) viruses, respectively. For the population targeted for vaccination, the adjusted VE was 44% (95% CI: -11 to 72), 36% (95% CI: -64 to 75) and 42% (95% CI: -29 to 74), respectively. These preliminary results in Spain suggest a suboptimal protective effect of the vaccine against circulating influenza viruses.
MESH
Adolescent | Adult | Aged | Aged, 80 and over | Case-Control Studies | Child | Child, Preschool | Female | Humans | Infant | Influenza A Virus, H1N1 Subtype | Influenza A Virus, H3N2 Subtype | Influenza Vaccines | Influenza, Human | Logistic Models | Male | Middle Aged | Population Surveillance | Spain | Vaccination | Young Adult | Outcome Assessment, Health Care
Online version
DOI
Collections
Files in this item
This item is licensed under a: Atribución 4.0 Internacional